Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinglin Yang

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Discover Oncology|July 16, 2025
GPC3: a novel mutated gene in pleuropulmonary blastomaJiahang Zeng, Xinying Wang, Yingyi Xu, et al.
Diabetes|May 22, 2016
Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet-Induced Insulin ResistanceWei Zhang, Mengrui Wu, Teayoun Kim, et al.
Cardiovascular Research|August 7, 2007
Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damageGuoliang Ding, Mingui Fu, Qianhong Qin, et al.
Cell Research|June 17, 2017
Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repairAjit Magadum, Yishu Ding, Lan He, et al.
Basic Research in Cardiology|February 23, 2013
Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathwayKe Chen, Lu Gao, Yu Liu, et al.
Journal of Hepatology|December 17, 2016
PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver diseaseKun Huang, Meng Du, Xin Tan, et al.
Hypertension (Dallas, Tex. : 1979)|June 30, 2010
Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signalingHe Huang, Qi-Zhu Tang, Ai-Bing Wang, et al.
Oncogene|October 15, 2022
A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogrammingHassan Yousefi, Maninder Khosla, Lothar Lauterboeck, et al.
Oncogene|February 9, 2023
Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogrammingHassan Yousefi, Maninder Khosla, Lothar Lauterboeck, et al.
Plos One|October 10, 2015
Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and FunctionJennifer M Kleinhenz, Tamara C Murphy, Anastassia P Pokutta-Paskaleva, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Discover Oncology|July 16, 2025
GPC3: a novel mutated gene in pleuropulmonary blastomaJiahang Zeng, Xinying Wang, Yingyi Xu, et al.
Diabetes|May 22, 2016
Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet-Induced Insulin ResistanceWei Zhang, Mengrui Wu, Teayoun Kim, et al.
Cardiovascular Research|August 7, 2007
Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damageGuoliang Ding, Mingui Fu, Qianhong Qin, et al.
Cell Research|June 17, 2017
Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repairAjit Magadum, Yishu Ding, Lan He, et al.
Basic Research in Cardiology|February 23, 2013
Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathwayKe Chen, Lu Gao, Yu Liu, et al.
Journal of Hepatology|December 17, 2016
PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver diseaseKun Huang, Meng Du, Xin Tan, et al.
Hypertension (Dallas, Tex. : 1979)|June 30, 2010
Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signalingHe Huang, Qi-Zhu Tang, Ai-Bing Wang, et al.
Oncogene|October 15, 2022
A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogrammingHassan Yousefi, Maninder Khosla, Lothar Lauterboeck, et al.
Oncogene|February 9, 2023
Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogrammingHassan Yousefi, Maninder Khosla, Lothar Lauterboeck, et al.
Plos One|October 10, 2015
Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and FunctionJennifer M Kleinhenz, Tamara C Murphy, Anastassia P Pokutta-Paskaleva, et al.
Pageof 19